Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Targeted Medical Pharma, Inc. - "Targeted Medical Pharma Third Quarter Recap"

TRGM

NEW YORK, NY / ACCESSWIRE / December 3, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In the post, Dr. Shell recaps the progress the Company made in the third quarter of 2014, including highlights from their business and clinical programs. Highlights included continued growth of the Company's current prescriber rate, an increase in new revenue from the direct to patient and pharmacy markets, and positive new data published in two separate scientific publications. Read the full blog post from Dr. Shell on TheChairmansBlog.com (http://www.thechairmansblog.com/targeted-medical-pharma/william-shell/targeted-medical-pharma-third-quarter-recap/).

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that is committed to drug discovery and development. The company currently develops and distributes medications for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and recently launched its first dietary supplement, Clearwayz(TM). The products are sold directly to physicians and pharmacies in the U.S. The company also is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I. Follow the Company on Twitter: @tmedpharma and on Facebook: www.facebook.com/TargetedMedicalPharma.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com.


SOURCE:
TheChairmansBlog.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today